NCT04948138View on ClinicalTrials.gov

Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

September 9, 2021

Study Completion Date

October 6, 2021

Conditions
MELAS Syndrome
Interventions
DIETARY_SUPPLEMENT

Glutamine oral supplementation

Oral supplementation with 10-15 g/day of glutamine (adjusted for weight and plasma concentrations).

Trial Locations (1)

28041

Hospital Universitario 12 de Octubre, Madrid

All Listed Sponsors
lead

Jesús González de la Aleja Tejera

OTHER